The World Vaccine Congress is an award-winning series of conferences and an exhibition that has grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is shown through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
Now in its 22nd annual, the World Vaccine Congress Europe, together with the co-located Veterinary Vaccine and Immuno-Oncology congresses, will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering. It will offer the chance to come together at a time where the disruption of COVID-19 has meant being able to network, learn and collaborate is as important as ever.
With 800+ potential customers in attendance there will be opportunities to find contacts who need to find solutions to challenges around the political, commercial and scientific issues in manufacturing, clinical trials, strategy, regulation, veterinary vaccines, immune profiling, AMR, respiratory, influenza, therapeutic and emerging diseases.
The World Vaccine Congress Europe has gone from strength to strength and has experienced fantastic growth. 2020 will be an unmissable edition where 800+ industry professionals will join us in Barcelona.
Threatened by infectious diseases and the unknown, it’s more important than ever to unite every stakeholder from policy makers in government, HTA/payers, healthcare professionals, academic scientists to manufacturers and new SMEs to challenge the existing vaccine lifecycle model, at the biggest and most established European vaccine meeting.
It is imperative for synergy between human and animal health to combat emerging zoonotic & transboundary diseases. The One Health holistic approach helps accelerate research & development and collaboration between human and animal health in key areas such as; Innovation, Zoonotic & Transboundary Diseases, Technology Platforms, Vaccines, Clinical Models, Adjuvants & Immunotherapy.
There is significant crossover between infectious disease and cancer when it comes to immune characterisation, interplay with T/B cells, multifaceted technology platforms, vaccine & antibody design. Join us as we discuss the importance of a united approach to advance infectious disease & cancer treatment. Regardless of whether your concerns are with the aging population, the young or the neglected, we cover such a broad scope of topics and diseases at such depth, that you’ll leave satisfied that you spent an incredibly productive few days with us.